A patient who started sertraline two weeks ago, is NPO (nothing by mouth) with gastrostomy tube feeding, lives in a dry environment, and is taking aspirin, now has a nosebleed; is this concerning and should the sertraline or aspirin be discontinued?

Management of Nosebleed in a Patient on Sertraline and Aspirin with G-Tube Feeding

This single nosebleed in a dry environment is not cause for alarm, and neither sertraline nor aspirin should be discontinued based on this isolated episode. 1

Why This Nosebleed Likely Occurred

Environmental factors are the primary culprit here:

• Dry indoor air creates fragile, hyperemic nasal mucosa that bleeds easily, particularly in patients receiving nothing by mouth who lack the natural humidification from oral breathing and swallowing 1
• G-tube feeding eliminates the normal moisturizing effect of oral intake, leaving the nasal passages more vulnerable to drying 2
• The combination of these factors makes anterior epistaxis (from Kiesselbach's plexus) highly likely even without medication effects 1

The Sertraline Question

Sertraline does carry a bleeding risk, but this manifests primarily as gastrointestinal bleeding or severe/recurrent epistaxis—not isolated nosebleeds:

• The FDA label explicitly warns that sertraline increases bleeding risk, especially when combined with aspirin or NSAIDs 3
• However, sertraline-associated epistaxis typically presents as recurrent, difficult-to-control bleeding, not a single episode in a dry environment 4, 5
• One case series documented that serotonin reuptake inhibitors were associated with post-procedural bleeding (adjusted OR 4.1) only when administered within 24 hours before invasive procedures—not with spontaneous minor bleeds 6
• The combination of SSRI plus aspirin increases GI bleeding risk 2.14-fold, but this evidence pertains to gastrointestinal mucosa, not nasal mucosa 7

Do not discontinue sertraline for this isolated nosebleed. The American Academy of Otolaryngology–Head and Neck Surgery recommends attempting first-line local measures before considering medication withdrawal unless bleeding is life-threatening 1

The Aspirin Question

Aspirin should absolutely be continued:

• The American Academy of Family Physicians explicitly states that aspirin should not be discontinued for standard epistaxis if the patient is at high cardiovascular risk 1
• Aspirin does increase epistaxis severity (one study showed increased surgical interventions and recurrence rates in aspirin users) 8, but the survival benefits in high-risk cardiovascular patients outweigh bleeding risks 1
• Standard epistaxis management protocol should be followed without stopping aspirin unless bleeding cannot be controlled with local measures 1

What You Should Do Now

Implement aggressive nasal moisturization immediately:

• Apply petroleum jelly to the anterior nasal mucosa 2–3 times daily to maintain moisture and prevent recurrence 1
• Use saline nasal sprays frequently throughout the day to keep nasal mucosa moist 1
• Place a bedside humidifier in the patient's room; humidified air prevents fragile, hyperemic nasal mucosa 1

Teach proper bleeding control technique for future episodes:

• Apply firm, continuous pressure to the soft lower third of the nose for 10–15 minutes without checking if bleeding stops; premature release is the most common cause of treatment failure 1
• If bleeding persists, apply 2 sprays of oxymetazoline (Afrin) into the bleeding nostril and resume compression for 5–10 minutes 1

Red Flags That Would Change Management

Seek urgent evaluation if any of these occur:

• Bleeding persists after 15 minutes of proper continuous compression 1
• Recurrent episodes (more than 3 recent nosebleeds) 1
• Bilateral recurrent nosebleeds (raises concern for hereditary hemorrhagic telangiectasia or systemic bleeding disorder) 1
• Hemodynamic instability, dizziness, or signs of significant blood loss 1
• Bleeding that recurs despite proper moisturization and environmental control 1

Common Pitfalls to Avoid

• Do not prematurely discontinue aspirin—cardiovascular risk trumps minor bleeding risk 1
• Do not attribute every minor bleed to sertraline—environmental factors are far more common causes of isolated epistaxis 1
• Do not overlook the role of dry air and NPO status—these are modifiable risk factors that should be addressed first 1
• Do not use bilateral simultaneous septal cautery if cauterization becomes necessary—this markedly increases septal perforation risk 1